Simulations Plus said a former FDA reviewer identified six common modeling errors in drug submissions that can trigger agency questions and weaken reviewer conf

Simulations Plus said a former FDA reviewer identified six common modeling errors in drug submissions that can trigger agency questions and weaken reviewer confidence. The warning comes as the company rolls out QSP Flex to help sponsors improve submission quality.